Skip to main content

Table 3 Results obtained for 11 patients who obtained target serum 25-hydroxyvitamin D (≥ 30 ng/mL) at 12 months

From: Vitamin D supplementation in systemic lupus erythematosus: relationship to disease activity, fatigue and the interferon signature gene expression

Variable

Time

Mean

SD

p value

SLEDAI-2K

Baseline

4.18

3.545

0.127

12 months

2.27

1.794

 

Clinical SLEDAI-2K

Baseline

2.18

2.892

0.140*

12 months

0.55

1.293

 

FSS

Baseline

4.27

1.261

0.011

12 months

3.33

1.930

 

VAS pain

Baseline

3.82

2.639

0.071

12 months

2.64

2.335

 

PSQI

Baseline

6.64

2.908

0.004

12 months

4.73

2.611

 

Serum 25-hydroxyvitamin D (ng/ml)

Baseline

23.45

6.138

< 0.001

12 months

37.27

5.293

 

Anti-dsDNA level (IU/ml)

Baseline

243.15

200.697

0.027

12 months

198.88

167.210

 
  1. The p values have been obtained using the Paired samples t test for normally distributed variables and the Wilcoxon signed ranks test for non-normally distributed variables (as denoted by *). Statistically significant results are highlighted in bold